@RayG It's safe to say Zilosul has been significantly derisked since the first patient was injected for EAP in February 2020.
Logically I can't see how this doesn't get above its previous levels - some dilution with $35m cap raise to consider as part of the equation here but seems like this could head back to $4+ in the ST..
Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA, page-34
-
- There are more pages in this discussion • 240 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.5¢ | 24.0¢ | $258.1K | 1.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 135166 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 101490 | 2 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |